BC
| |
Birchview Capital, LP13F | |
| Birchview Capital, LP | |
| Last update 2025-05-16 | 68 Stocks (4 new) |
| Value $115.00 Mil | Turnover 4 % |
Birchview Capital, LP Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY | Bristol-Myers Squibb Co | 685,192 | 41,789.8 | 0% | 36.290 | 0% | 0.030 | -20.45% | -16.25% | 94,326.0 | Drug Manufacturers | |
CORT | Corcept Therapeutics Inc | 66,000 | 7,538.5 | -10.81% | 6.550 | -0.33% | 0.060 | +29.18% | +45.31% | 7,764.6 | Biotechnology | |
ACAD | ACADIA Pharmaceuticals Inc | 263,400 | 4,375.1 | -22.16% | 3.800 | -1.12% | 0.160 | +28.68% | +20.54% | 3,702.0 | Biotechnology | |
PRTA | Prothena Corp PLC | 332,974 | 4,120.6 | +9.32% | 3.580 | +0.31% | 0.620 | -53.04% | -55.88% | 328.9 | Biotechnology | |
BDSX | Biodesix Inc | 5,736,113 | 3,586.2 | +2.78% | 3.110 | +0.08% | 3.920 | -64.70% | -83.56% | 36.9 | Medical Diagnostics & Research | |
NBIX | Neurocrine Biosciences Inc | 30,240 | 3,344.5 | 0% | 2.900 | 0% | 0.030 | +10.01% | -8.12% | 12,411.8 | Drug Manufacturers | |
ELUT | Elutia Inc | 1,187,735 | 3,005.0 | -3.08% | 2.610 | -0.12% | 2.910 | -21.43% | -44.12% | 85.9 | Medical Devices & Instruments | |
AXGN | Axogen Inc | 161,000 | 2,978.5 | -18.27% | 2.590 | -0.48% | 0.350 | -44.76% | -36.35% | 477.8 | Medical Devices & Instruments | |
PHR | Phreesia Inc | 114,700 | 2,931.7 | 0% | 2.550 | 0% | 0.200 | +4.86% | +13.24% | 1,695.3 | Healthcare Providers & Services | |
TVTX | Travere Therapeutics Inc | 138,000 | 2,473.0 | -6.76% | 2.150 | -0.14% | 0.160 | -27.44% | -15.15% | 1,312.5 | Biotechnology |
Birchview Capital, LP's Historical Top Holdings Breakdowns
Birchview Capital, LP's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
ACAD | ACADIA Pharmaceuticals Inc | 2025-03-31 | Reduce Reduce | -1.12% | 16.61 ($18.17) 20.29 | $22.12 | 21.74% | Reduce -22.16% | 263,400 | -75,000 | |
UTHR | United Therapeutics Corp | 2025-03-31 | Reduce Reduce | -0.72% | 304.42 ($342.7) 380.78 | $284.23 | -17.06% | Reduce -25% | 7,500 | -2,500 | |
QURE | uniQure NV | 2025-03-31 | Add Add | +0.64% | 10.6 ($14.02) 18.08 | $13.88 | -1.00% | Add 343.49% | 88,697 | 68,697 | |
MASI | Masimo Corp | 2025-03-31 | Reduce Reduce | -0.54% | 163.55 ($173.51) 190.63 | $168.03 | -3.16% | Reduce -26.18% | 11,280 | -4,000 | |
AXGN | Axogen Inc | 2025-03-31 | Reduce Reduce | -0.48% | 14.56 ($18.05) 20.11 | $10.49 | -41.88% | Reduce -18.27% | 161,000 | -36,000 | |
KIDS | OrthoPediatrics Corp | 2025-03-31 | New Buy New Buy | +0.43% | 22.87 ($24.7) 27.24 | $21.33 | -13.64% | New holding | 20,000 | 20,000 | |
SLDB | Solid Biosciences Inc | 2025-03-31 | New Buy New Buy | +0.41% | 2.88 ($4.28) 6.47 | $4.72 | 10.28% | New holding | 128,768 | 128,768 | |
SRPT | Sarepta Therapeutics Inc | 2025-03-31 | Sold Out Sold Out | -0.35% | 63.82 ($105.27) 127.89 | $17.09 | -83.77% | Sold Out | 0 | -3,500 | |
CORT | Corcept Therapeutics Inc | 2025-03-31 | Reduce Reduce | -0.33% | 49.85 ($60.87) 114.22 | $73.22 | 20.29% | Reduce -10.81% | 66,000 | -8,000 | |
XENE | Xenon Pharmaceuticals Inc | 2025-03-31 | Add Add | +0.32% | 33.55 ($37.97) 40.74 | $32.41 | -14.64% | Add 110% | 21,000 | 11,000 |
Birchview Capital, LP Total Holding History ($B)
Birchview Capital, LP's Asset Allocation
Birchview Capital, LP Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
Birchview Capital, LP's Hypothetical Growth since 2025-03-31
Birchview Capital, LP's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
Birchview Capital, LP's Holdings Heat Map
Size field:
Birchview Capital, LP's Holdings Bubble Chart
Birchview Capital, LP News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers